{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T18:22:50Z","timestamp":1794248570161,"version":"4.9.0"},"reference-count":106,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T00:00:00Z","timestamp":1781740800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82360469"],"award-info":[{"award-number":["82360469"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004775","name":"Gansu Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["24JRRA937"],"award-info":[{"award-number":["24JRRA937"]}],"id":[{"id":"10.13039\/501100004775","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004775","name":"Gansu Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["25JRRA1301"],"award-info":[{"award-number":["25JRRA1301"]}],"id":[{"id":"10.13039\/501100004775","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["iScience"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.isci.2026.116670","type":"journal-article","created":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T15:03:45Z","timestamp":1783695825000},"page":"116670","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["The role of serologic biomarkers \u201cliquid biopsy\u201d in the fight against breast cancer: From biological foundations to clinical impact"],"prefix":"10.1016","volume":"29","author":[{"given":"Yan","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongrong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0108-9230","authenticated-orcid":false,"given":"Jianying","family":"Pei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.isci.2026.116670_bib1","first-page":"10","article-title":"Cancer statistics, 2025","volume":"75","author":"Siegel","year":"2025","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.isci.2026.116670_bib2","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1093\/eurpub\/ckac047","article-title":"Change in effectiveness of mammography screening with decreasing breast cancer mortality: a population-based study","volume":"32","author":"Christiansen","year":"2022","journal-title":"Eur. J. Publ. Health"},{"key":"10.1016\/j.isci.2026.116670_bib3","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-71382-3","article-title":"Currently favored sampling practices for tumor sequencing can produce optimal results in the clinical setting","volume":"10","author":"Pongor","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.isci.2026.116670_bib4","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10153309","article-title":"Quantitative Breast Density in Contrast-Enhanced Mammography","volume":"10","author":"Gennaro","year":"2021","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.isci.2026.116670_bib5","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.annonc.2025.01.021","article-title":"Whole genome sequencing-powered ctDNA sequencing for breast cancer detection","volume":"36","author":"Garcia-Murillas","year":"2025","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.isci.2026.116670_bib6","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1186\/s12967-020-02449-y","article-title":"Patient specific circulating tumor DNA fingerprints to monitor treatment response across multiple tumors","volume":"18","author":"Li","year":"2020","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.isci.2026.116670_bib7","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.15252\/emmm.201404913","article-title":"Serial monitoring of circulating tumor DNA in patients with primary breast cancer for detection of occult metastatic disease","volume":"7","author":"Olsson","year":"2015","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.isci.2026.116670_bib8","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abc4308","article-title":"A mathematical model of ctDNA shedding predicts tumor detection size","volume":"6","author":"Avanzini","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.isci.2026.116670_bib9","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21249457","article-title":"Current Status of Circulating Tumor Cells, Circulating Tumor DNA, and Exosomes in Breast Cancer Liquid Biopsies","volume":"21","author":"Tellez-Gabriel","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.isci.2026.116670_bib10","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s10555-016-9629-x","article-title":"Origins, structures, and functions of circulating DNA in oncology","volume":"35","author":"Thierry","year":"2016","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.isci.2026.116670_bib11","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/5585148","article-title":"Optimization of Preanalytical Variables for cfDNA Processing and Detection of ctDNA in Archival Plasma Samples","volume":"2021","author":"Nesic","year":"2021","journal-title":"Biomed Res. Int."},{"key":"10.1016\/j.isci.2026.116670_bib12","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9051543","article-title":"Increased Cell-Free DNA Plasma Concentration Following Liver Transplantation Is Linked to Portal Hepatitis and Inferior Survival","volume":"9","author":"Krenzien","year":"2020","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.isci.2026.116670_bib13","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/nm.4333","article-title":"Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients","volume":"23","author":"Zehir","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.isci.2026.116670_bib14","doi-asserted-by":"crossref","first-page":"7495","DOI":"10.1038\/s41467-022-35245-x","article-title":"Tissue and liquid biopsy profiling reveal convergent tumor evolution and therapy evasion in breast cancer","volume":"13","author":"Sivakumar","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2026.116670_bib15","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s10549-021-06270-z","article-title":"Evaluation of endocrine resistance using ESR1 genotyping of circulating tumor cells and plasma DNA","volume":"188","author":"Sundaresan","year":"2021","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.isci.2026.116670_bib16","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3007094","article-title":"Detection of circulating tumor DNA in early- and late-stage human malignancies","volume":"6","author":"Bettegowda","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.isci.2026.116670_bib17","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nature12065","article-title":"Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA","volume":"497","author":"Murtaza","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.isci.2026.116670_bib18","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25168594","article-title":"Liquid Biopsy in the Clinical Management of Cancers","volume":"25","author":"Ho","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.isci.2026.116670_bib19","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1080\/17501911.2025.2548755","article-title":"DNA methylation biomarkers for the diagnosis and treatment management of breast cancer: where are we now?","volume":"17","author":"Williams","year":"2025","journal-title":"Epigenomics"},{"key":"10.1016\/j.isci.2026.116670_bib20","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s10020-019-0082-5","article-title":"Tag-based next generation sequencing: a feasible and reliable assay for EGFR T790M mutation detection in circulating tumor DNA of non small cell lung cancer patients","volume":"25","author":"Dono","year":"2019","journal-title":"Mol. Med."},{"key":"10.1016\/j.isci.2026.116670_bib21","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/nm.3519","article-title":"An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage","volume":"20","author":"Newman","year":"2014","journal-title":"Nat. Med."},{"key":"10.1016\/j.isci.2026.116670_bib22","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26062486","article-title":"Circulating Tumor DNA as a Real-Time Biomarker for Minimal Residual Disease and Recurrence Prediction in Stage II Colorectal Cancer: A Systematic Review and Meta-Analysis","volume":"26","author":"Negro","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.isci.2026.116670_bib23","doi-asserted-by":"crossref","first-page":"4255","DOI":"10.1158\/1078-0432.CCR-18-3663","article-title":"Personalized Detection of Circulating Tumor DNA Antedates Breast Cancer Metastatic Recurrence","volume":"25","author":"Coombes","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.isci.2026.116670_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.jlb.2024.100141","article-title":"In vitro size-selection of short circulating tumor DNA fragments from late-stage lung cancer patients enhance the detection of mutations and aneuploidies","volume":"4","author":"Maansson","year":"2024","journal-title":"J. Liq. Biopsy"},{"key":"10.1016\/j.isci.2026.116670_bib25","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/s41586-019-1272-6","article-title":"Genome-wide cell-free DNA fragmentation in patients with cancer","volume":"570","author":"Cristiano","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.isci.2026.116670_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0165089","article-title":"Chromosomal Instability Estimation Based on Next Generation Sequencing and Single Cell Genome Wide Copy Number Variation Analysis","volume":"11","author":"Greene","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.isci.2026.116670_bib27","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1093\/annonc\/mdq052","article-title":"Clinical value of circulating endothelial cells and circulating tumor cells in metastatic breast cancer patients treated first line with bevacizumab and chemotherapy","volume":"21","author":"Bidard","year":"2010","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.isci.2026.116670_bib28","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1238332","article-title":"Development and clinical validation of a microfluidic-based platform for CTC enrichment and downstream molecular analysis","volume":"13","author":"Cai","year":"2023","journal-title":"Front. Oncol."},{"key":"10.1016\/j.isci.2026.116670_bib29","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s12943-024-01984-2","article-title":"Diagnostic leukapheresis reveals distinct phenotypes of NSCLC circulating tumor cells","volume":"23","author":"Rieckmann","year":"2024","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.isci.2026.116670_bib30","doi-asserted-by":"crossref","first-page":"16580","DOI":"10.1073\/pnas.1313594110","article-title":"Diagnostic leukapheresis enables reliable detection of circulating tumor cells of nonmetastatic cancer patients","volume":"110","author":"Fischer","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.isci.2026.116670_bib31","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1204224","article-title":"Serum-derived extracellular vesicles from breast cancer patients contribute to differential regulation of T-cell-mediated immune-escape mechanisms in breast cancer subtypes","volume":"14","author":"Graham","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.isci.2026.116670_bib32","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2024.1337706","article-title":"MicroRNA as a promising molecular biomarker in the diagnosis of breast cancer","volume":"11","author":"de Miranda","year":"2024","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.isci.2026.116670_bib33","article-title":"Potential utility of miRNAs for liquid biopsy in breast cancer","volume":"12","author":"Liu","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.isci.2026.116670_bib34","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines11113007","article-title":"MicroRNAs as Molecular Biomarkers for the Characterization of Basal-like Breast Tumor Subtype","volume":"11","author":"Tariq","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.isci.2026.116670_bib35","doi-asserted-by":"crossref","first-page":"181","DOI":"10.3892\/ol.2024.14314","article-title":"Liquid biopsy utilizing miRNA in patients with advanced breast cancer treated with cyclin-dependent kinase 4\/6 inhibitors","volume":"27","author":"Kubeczko","year":"2024","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.isci.2026.116670_bib36","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.trsl.2020.04.002","article-title":"Liquid biopsy for breast cancer using extracellular vesicles and cell-free microRNAs as biomarkers","volume":"223","author":"Ozawa","year":"2020","journal-title":"Transl. Res."},{"key":"10.1016\/j.isci.2026.116670_bib37","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s12943-022-01509-9","article-title":"Exosomes as a new frontier of cancer liquid biopsy","volume":"21","author":"Yu","year":"2022","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.isci.2026.116670_bib38","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.omtn.2017.11.014","article-title":"Exosomes in Cancer Liquid Biopsy: A Focus on Breast Cancer","volume":"10","author":"Halvaei","year":"2018","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.isci.2026.116670_bib39","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1186\/s12951-024-02863-0","article-title":"The new advance of exosome-based liquid biopsy for cancer diagnosis","volume":"22","author":"Tang","year":"2024","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.isci.2026.116670_bib40","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines9030312","article-title":"The Role of Exosomes in Breast Cancer Diagnosis","volume":"9","author":"Piombino","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.isci.2026.116670_bib41","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23169371","article-title":"Breast Cancer-Delivered Exosomal miRNA as Liquid Biopsy Biomarkers for Metastasis Prediction: A Focus on Translational Research with Clinical Applicability","volume":"23","author":"Baldasici","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.isci.2026.116670_bib42","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27217145","article-title":"Recent Advances in Exosomal miRNA Biosensing for Liquid Biopsy","volume":"27","author":"Lin","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.isci.2026.116670_bib43","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1056\/NEJMoa040766","article-title":"Circulating tumor cells, disease progression, and survival in metastatic breast cancer","volume":"351","author":"Cristofanilli","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.isci.2026.116670_bib44","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aac7551","article-title":"Analysis of ESR1 mutation in circulating tumor DNA demonstrates evolution during therapy for metastatic breast cancer","volume":"7","author":"Schiavon","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.isci.2026.116670_bib45","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.tranon.2019.11.007","article-title":"Clinical Implications of Monitoring ESR1 Mutations by Circulating Tumor DNA in Estrogen Receptor Positive Metastatic Breast Cancer: A Pilot Study","volume":"13","author":"Li","year":"2020","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.isci.2026.116670_bib46","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1221773","article-title":"Validation of liquid biopsy for ESR1-mutation analysis in hormone-sensitive breast cancer: a pooled meta-analysis","volume":"13","author":"Najim","year":"2023","journal-title":"Front. Oncol."},{"key":"10.1016\/j.isci.2026.116670_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2023.102642","article-title":"ESR1 mutations in HR+\/HER2-metastatic breast cancer: Enhancing the accuracy of ctDNA testing","volume":"121","author":"Venetis","year":"2023","journal-title":"Cancer Treat Rev."},{"key":"10.1016\/j.isci.2026.116670_bib48","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.tranon.2017.07.004","article-title":"Comparison of ESR1 Mutations in Tumor Tissue and Matched Plasma Samples from Metastatic Breast Cancer Patients","volume":"10","author":"Takeshita","year":"2017","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.isci.2026.116670_bib49","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.625636","article-title":"ESR1 Gene Mutation in Hormone Receptor-Positive HER2-Negative Metastatic Breast Cancer Patients: Concordance Between Tumor Tissue and Circulating Tumor DNA Analysis","volume":"11","author":"Urso","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.isci.2026.116670_bib50","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/S1470-2045(17)30376-5","article-title":"Buparlisib plus fulvestrant versus placebo plus fulvestrant in postmenopausal, hormone receptor-positive, HER2-negative, advanced breast cancer (BELLE-2): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"18","author":"Baselga","year":"2017","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.isci.2026.116670_bib51","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s13073-023-01181-8","article-title":"Multiple PIK3CA mutation clonality correlates with outcomes in taselisib + fulvestrant-treated ER+\/HER2-PIK3CA-mutated breast cancers","volume":"15","author":"Hutchinson","year":"2023","journal-title":"Genome Med."},{"key":"10.1016\/j.isci.2026.116670_bib52","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1056\/NEJMoa1813904","article-title":"Alpelisib for PIK3CA-Mutated, Hormone Receptor-Positive Advanced Breast Cancer","volume":"380","author":"Andr\u00e9","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.isci.2026.116670_bib53","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/S1470-2045(20)30444-7","article-title":"Circulating tumour DNA analysis to direct therapy in advanced breast cancer (plasmaMATCH): a multicentre, multicohort, phase 2a, platform trial","volume":"21","author":"Turner","year":"2020","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.isci.2026.116670_bib54","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1038\/s41467-021-22605-2","article-title":"Genomic profile of advanced breast cancer in circulating tumour DNA","volume":"12","author":"Kingston","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2026.116670_bib55","doi-asserted-by":"crossref","first-page":"3209","DOI":"10.2217\/fon-2019-0370","article-title":"EMERALD: Phase III trial of elacestrant (RAD1901) vs endocrine therapy for previously treated ER+ advanced breast cancer","volume":"15","author":"Bardia","year":"2019","journal-title":"Future Oncol."},{"key":"10.1016\/j.isci.2026.116670_bib56","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1158\/1078-0432.CCR-24-0651","article-title":"The Prognostic and Predictive Impact of ctDNA Levels in Patients with Advanced Breast Cancer Enrolled on the plasmaMATCH Trial","volume":"32","author":"Browne","year":"2026","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.isci.2026.116670_bib57","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s13058-020-01290-x","article-title":"Risk of early progression according to circulating ESR1 mutation, CA-15.3 and cfDNA increases under first-line anti-aromatase treatment in metastatic breast cancer","volume":"22","author":"Clatot","year":"2020","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.isci.2026.116670_bib58","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.annonc.2022.11.005","article-title":"Results of the c-TRAK TN trial: a clinical trial utilising ctDNA mutation tracking to detect molecular residual disease and trigger intervention in patients with moderate- and high-risk early-stage triple-negative breast cancer","volume":"34","author":"Turner","year":"2023","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.isci.2026.116670_bib59","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/s41571-019-0187-3","article-title":"Liquid biopsy and minimal residual disease - latest advances and implications for cure","volume":"16","author":"Pantel","year":"2019","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.isci.2026.116670_bib60","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aab0021","article-title":"Mutation tracking in circulating tumor DNA predicts relapse in early breast cancer","volume":"7","author":"Garcia-Murillas","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.isci.2026.116670_bib61","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1001\/jamaoncol.2019.1838","article-title":"Assessment of Molecular Relapse Detection in Early-Stage Breast Cancer","volume":"5","author":"Garcia-Murillas","year":"2019","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.isci.2026.116670_bib62","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1001\/jamaoncol.2020.2295","article-title":"Association of Circulating Tumor DNA and Circulating Tumor Cells After Neoadjuvant Chemotherapy With Disease Recurrence in Patients With Triple-Negative Breast Cancer: Preplanned Secondary Analysis of the BRE12-158 Randomized Clinical Trial","volume":"6","author":"Radovich","year":"2020","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.isci.2026.116670_bib63","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/S1470-2045(22)00555-1","article-title":"Switch to fulvestrant and palbociclib versus no switch in advanced breast cancer with rising ESR1 mutation during aromatase inhibitor and palbociclib therapy (PADA-1): a randomised, open-label, multicentre, phase 3 trial","volume":"23","author":"Bidard","year":"2022","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.isci.2026.116670_bib64","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-88094-1","article-title":"Mutational profiling using liquid biopsy to guide targeted therapy in patients with metastatic cancer","volume":"15","author":"Mazouji","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.isci.2026.116670_bib65","doi-asserted-by":"crossref","DOI":"10.3390\/cells13221884","article-title":"Circulating Micro-RNAs Predict the Risk of Recurrence in Triple-Negative Breast Cancer","volume":"13","author":"Kujala","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.isci.2026.116670_bib66","doi-asserted-by":"crossref","DOI":"10.1016\/j.cca.2024.120063","article-title":"Liquid biopsy biomarkers in breast cancer: An overview of systematic reviews","volume":"566","author":"Tayeb","year":"2025","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.isci.2026.116670_bib67","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s13073-021-00902-1","article-title":"Integrative statistical analyses of multiple liquid biopsy analytes in metastatic breast cancer","volume":"13","author":"Keup","year":"2021","journal-title":"Genome Med."},{"key":"10.1016\/j.isci.2026.116670_bib68","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.217325","article-title":"Integrating machine learning-predicted circulating tumor cells (CTCs) and circulating tumor DNA (ctDNA) in metastatic breast cancer: A proof of principle study on endocrine resistance profiling","volume":"609","author":"Gerratana","year":"2025","journal-title":"Cancer Lett."},{"key":"10.1016\/j.isci.2026.116670_bib69","doi-asserted-by":"crossref","DOI":"10.3390\/medicina61040581","article-title":"Proposed Comprehensive Methodology Integrated with Explainable Artificial Intelligence for Prediction of Possible Biomarkers in Metabolomics Panel of Plasma Samples for Breast Cancer Detection","volume":"61","author":"Colak","year":"2025","journal-title":"Medicina"},{"key":"10.1016\/j.isci.2026.116670_bib70","doi-asserted-by":"crossref","first-page":"5841","DOI":"10.1038\/s41598-024-56419-1","article-title":"Precision cancer classification using liquid biopsy and advanced machine learning techniques","volume":"14","author":"Eledkawy","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.isci.2026.116670_bib71","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbad236","article-title":"Explainable AI for Bioinformatics: Methods, Tools and Applications","volume":"24","author":"Karim","year":"2023","journal-title":"Briefings Bioinf."},{"key":"10.1016\/j.isci.2026.116670_bib72","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/clinchem\/hvad196","article-title":"Looking to the Future of Early Detection in Cancer: Liquid Biopsies, Imaging, and Artificial Intelligence","volume":"70","author":"Foser","year":"2024","journal-title":"Clin. Chem."},{"key":"10.1016\/j.isci.2026.116670_bib73","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2023.106544","article-title":"An explainable AI-driven biomarker discovery framework for Non-Small Cell Lung Cancer classification","volume":"153","author":"Dwivedi","year":"2023","journal-title":"Comput. Biol. Med."},{"key":"10.1016\/j.isci.2026.116670_bib74","article-title":"Personalized circulating tumor DNA dynamics predict survival and response to immune checkpoint blockade in recurrent\/metastatic head and neck cancer","author":"Ruiz-Torres","year":"2025","journal-title":"medRxiv"},{"key":"10.1016\/j.isci.2026.116670_bib75","doi-asserted-by":"crossref","first-page":"405","DOI":"10.4048\/jbc.2023.26.e45","article-title":"Artificial Intelligence in Breast Cancer Diagnosis and Personalized Medicine","volume":"26","author":"Ahn","year":"2023","journal-title":"J. Breast Cancer"},{"key":"10.1016\/j.isci.2026.116670_bib76","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2024.102769","article-title":"Development and validation of an integrated system for lung cancer screening and post-screening pulmonary nodules management: a proof-of-concept study (ASCEND-LUNG)","volume":"75","author":"Jin","year":"2024","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.isci.2026.116670_bib77","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1038\/s41591-024-03040-4","article-title":"Ultrasensitive plasma-based monitoring of tumor burden using machine-learning-guided signal enrichment","volume":"30","author":"Widman","year":"2024","journal-title":"Nat. Med."},{"key":"10.1016\/j.isci.2026.116670_bib78","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jmoldx.2023.10.002","article-title":"Pan-Tumor Analytical Validation and Osimertinib Clinical Validation in EGFR Mutant Non\u2013Small-Cell Lung Cancer, Supporting the First Next-Generation Sequencing Liquid Biopsy in Vitro Diagnostic","volume":"26","author":"Gray","year":"2024","journal-title":"J. Mol. Diagn."},{"key":"10.1016\/j.isci.2026.116670_bib79","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.lungcan.2021.10.007","article-title":"Clinical validation of Guardant360 CDx as a blood-based companion diagnostic for sotorasib","volume":"166","author":"Bauml","year":"2022","journal-title":"Lung Cancer"},{"key":"10.1016\/j.isci.2026.116670_bib80","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.trecan.2024.12.001","article-title":"Artificial intelligence-based biomarkers for treatment decisions in oncology","volume":"11","author":"Ligero","year":"2025","journal-title":"Trends Cancer"},{"key":"10.1016\/j.isci.2026.116670_bib81","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1093\/annonc\/mdz227","article-title":"How liquid biopsies can change clinical practice in oncology","volume":"30","author":"Siravegna","year":"2019","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.isci.2026.116670_bib82","doi-asserted-by":"crossref","first-page":"4613","DOI":"10.1158\/1078-0432.CCR-13-3063","article-title":"Noninvasive diagnosis of actionable mutations by deep sequencing of circulating free DNA in lung cancer from never-smokers: a proof-of-concept study from BioCAST\/IFCT-1002","volume":"20","author":"Couraud","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.isci.2026.116670_bib83","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.lungcan.2015.10.004","article-title":"EGFR mutation detection in ctDNA from NSCLC patient plasma: A cross-platform comparison of leading technologies to support the clinical development of AZD9291","volume":"90","author":"Thress","year":"2015","journal-title":"Lung Cancer"},{"key":"10.1016\/j.isci.2026.116670_bib84","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1373\/clinchem.2015.241414","article-title":"Diagnostic Accuracy of Noninvasive Genotyping of EGFR in Lung Cancer Patients by Deep Sequencing of Plasma Cell-Free DNA","volume":"61","author":"Uchida","year":"2015","journal-title":"Clin. Chem."},{"key":"10.1016\/j.isci.2026.116670_bib85","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1158\/1078-0432.CCR-15-1627-T","article-title":"Bias-Corrected Targeted Next-Generation Sequencing for Rapid, Multiplexed Detection of Actionable Alterations in Cell-Free DNA from Advanced Lung Cancer Patients","volume":"22","author":"Paweletz","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.isci.2026.116670_bib86","doi-asserted-by":"crossref","first-page":"6005","DOI":"10.1073\/pnas.1601311113","article-title":"Ultra-deep sequencing detects ovarian cancer cells in peritoneal fluid and reveals somatic TP53 mutations in noncancerous tissues","volume":"113","author":"Krimmel","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.isci.2026.116670_bib87","first-page":"91","article-title":"A Genomic Analysis Workflow for Colorectal Cancer Precision Oncology","volume":"18","author":"Corti","year":"2019","journal-title":"Clin. Colorectal Cancer"},{"key":"10.1016\/j.isci.2026.116670_bib88","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aan2415","article-title":"Direct detection of early-stage cancers using circulating tumor DNA","volume":"9","author":"Phallen","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.isci.2026.116670_bib89","doi-asserted-by":"crossref","first-page":"3539","DOI":"10.1158\/1078-0432.CCR-17-3831","article-title":"Validation of a Plasma-Based Comprehensive Cancer Genotyping Assay Utilizing Orthogonal Tissue- and Plasma-Based Methodologies","volume":"24","author":"Odegaard","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.isci.2026.116670_bib90","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1001\/jamaoncol.2017.4027","article-title":"Patient-Paired Sample Congruence Between 2 Commercial Liquid Biopsy Tests","volume":"4","author":"Torga","year":"2018","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.isci.2026.116670_bib91","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.5858\/arpa.2018-0901-SA","article-title":"Circulating Tumor DNA Analysis in Patients With Cancer: American Society of Clinical Oncology and College of American Pathologists Joint Review","volume":"142","author":"Merker","year":"2018","journal-title":"Arch. Pathol. Lab Med."},{"key":"10.1016\/j.isci.2026.116670_bib92","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1093\/jnci\/djae179","article-title":"NCI workshop on ctDNA in cancer treatment and clinical care","volume":"116","author":"Sorg","year":"2024","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.isci.2026.116670_bib93","doi-asserted-by":"crossref","first-page":"7375","DOI":"10.1038\/s41598-018-25810-0","article-title":"Evaluation of pre-analytical factors affecting plasma DNA analysis","volume":"8","author":"Markus","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.isci.2026.116670_bib94","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202216505","article-title":"Comparison of tumor-informed and tumor-na\u00efve sequencing assays for ctDNA detection in breast cancer","volume":"15","author":"Santonja","year":"2023","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.isci.2026.116670_bib95","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jmoldx.2022.10.004","article-title":"A Micro-Costing Framework for Circulating Tumor DNA Testing in Dutch Clinical Practice","volume":"25","author":"Kramer","year":"2023","journal-title":"J. Mol. Diagn."},{"key":"10.1016\/j.isci.2026.116670_bib96","doi-asserted-by":"crossref","first-page":"e15049","DOI":"10.1200\/JCO.2023.41.16_suppl.e15049","article-title":"Validation of a whole exome\/whole transcriptome liquid biopsy assay with correction for clonal hematopoiesis","volume":"41","author":"Perdigones Borderias","year":"2023","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.isci.2026.116670_bib97","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1158\/1078-0432.CCR-23-2326","article-title":"Comparison of Circulating Tumor DNA Assays for Molecular Residual Disease Detection in Early-Stage Triple-Negative Breast Cancer","volume":"30","author":"Coakley","year":"2024","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.isci.2026.116670_bib98","article-title":"Validation of ctDNA Quality Control Materials Through a Precompetitive Collaboration of the Foundation for the National Institutes of Health","volume":"5","author":"Williams","year":"2021","journal-title":"JCO Precis. Oncol."},{"key":"10.1016\/j.isci.2026.116670_bib99","doi-asserted-by":"crossref","DOI":"10.1016\/j.jlb.2025.100286","article-title":"Cancer in a drop: Liquid biopsy highlights from San Antonio Breast Cancer Symposium (SABCS) 2024","volume":"7","author":"Pontolillo","year":"2025","journal-title":"J. Liq. Biopsy"},{"key":"10.1016\/j.isci.2026.116670_bib100","doi-asserted-by":"crossref","DOI":"10.1016\/j.trac.2022.116806","article-title":"Microfluidic platforms integrated with nano-sensors for point-of-care bioanalysis","volume":"157","author":"Tavakoli","year":"2022","journal-title":"Trends Anal. Chem."},{"key":"10.1016\/j.isci.2026.116670_bib101","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/s41551-021-00760-7","article-title":"CRISPR-based diagnostics","volume":"5","author":"Kaminski","year":"2021","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.isci.2026.116670_bib102","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202214987","article-title":"CRISPR-Cas Biochemistry and CRISPR-Based Molecular Diagnostics","volume":"62","author":"Weng","year":"2023","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.isci.2026.116670_bib103","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/s41416-022-01768-9","article-title":"Circulating tumour cells in the -omics era: how far are we from achieving the \u2018singularity\u2019?","volume":"127","author":"Visal","year":"2022","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.isci.2026.116670_bib104","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1158\/0008-5472.CAN-15-0145","article-title":"Ex Vivo Culture of CTCs: An Emerging Resource to Guide Cancer Therapy","volume":"75","author":"Maheswaran","year":"2015","journal-title":"Cancer Res."},{"key":"10.1016\/j.isci.2026.116670_bib105","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24032505","article-title":"Liquid Biopsy for Lung Cancer: Up-to-Date and Perspectives for Screening Programs","volume":"24","author":"Casagrande","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.isci.2026.116670_bib106","doi-asserted-by":"crossref","first-page":"S283","DOI":"10.3233\/TUB-220044","article-title":"Circulating tumor DNA (ctDNA) as a biomarker for lung cancer: Early detection, monitoring and therapy prediction","volume":"46","author":"Duffy","year":"2024","journal-title":"Tumour Biol."}],"container-title":["iScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004226020468?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004226020468?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T17:54:28Z","timestamp":1794246868000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589004226020468"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":106,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S2589004226020468"],"URL":"https:\/\/doi.org\/10.1016\/j.isci.2026.116670","relation":{},"ISSN":["2589-0042"],"issn-type":[{"value":"2589-0042","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of serologic biomarkers \u201cliquid biopsy\u201d in the fight against breast cancer: From biological foundations to clinical impact","name":"articletitle","label":"Article Title"},{"value":"iScience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.isci.2026.116670","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Gansu Provincial Maternity and Child care Hospital. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"116670"}}